Literature DB >> 18187957

Elevate level of glycosaminoglycans and altered sulfation pattern of chondroitin sulfate are associated with differentiation status and histological type of human primary hepatic carcinoma.

Huizhong Lv1, Guangli Yu, Linlin Sun, Zheng Zhang, Xia Zhao, Wengang Chai.   

Abstract

OBJECTIVES: The characteristics of glycosaminoglycans (GAGs) in many carcinomas have been reported to be different from those in normal tissues, which can be used as prognostic indices in some cancers. However, the difference in GAG characteristics among various differentiation status or histological types of the same cancer has not been described. The aim of this study was to investigate the relationship between GAG characteristics and human primary hepatic carcinomas of divers differentiation status or histological type.
METHODS: GAGs from intrahepatic cholangiocarcinomas and differently differentiated hepatocellular carcinomas were extracted, purified and enzymatically digested. Their content, relative molecular size distribution and disaccharide composition were analyzed and compared using electrophoresis and high-performance liquid chromatography.
RESULTS: A progressive increase in the content of chondroitin sulfate, low molecular size GAGs, and nonsulfated and disulfated chondroitin sulfate disaccharide units, together with a gradual decrease in heparan sulfate, have been found as the differentiation status of hepatocellular carcinoma became poorer. A significant increase in hyaluronic acid, which only slightly increased in hepatocellular carcinoma, was found in intrahepatic cholangiocarcinomas.
CONCLUSION: The alterations in GAG characteristics in primary hepatic carcinoma were associated with both the differentiation status and the histological type of the tumor. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18187957     DOI: 10.1159/000113145

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  19 in total

1.  A structural analysis of glycosaminoglycans from lethal and nonlethal breast cancer tissues: toward a novel class of theragnostics for personalized medicine in oncology?

Authors:  Amanda Weyers; Bo Yang; Dae Sung Yoon; Jong-Hwan Park; Fuming Zhang; Kyung Bok Lee; Robert J Linhardt
Journal:  OMICS       Date:  2012-03

2.  Ex vivo assessment of mouse cervical remodeling through pregnancy via 23Na MRS.

Authors:  Xiang Xu; Yucel Akgul; Mala Mahendroo; Alexej Jerschow
Journal:  NMR Biomed       Date:  2010-10       Impact factor: 4.044

Review 3.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 4.  Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches.

Authors:  Atit Silsirivanit; Kanlayanee Sawanyawisuth; Gregory J Riggins; Chaisiri Wongkham
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-02-12       Impact factor: 7.027

5.  Overexpression of hyaluronan-binding protein 1 (HABP1/p32/gC1qR) in HepG2 cells leads to increased hyaluronan synthesis and cell proliferation by up-regulation of cyclin D1 in AKT-dependent pathway.

Authors:  Rachna Kaul; Paramita Saha; Mallampati Saradhi; Ramachandra L A Prasad; Soumya Chatterjee; Ilora Ghosh; Rakesh K Tyagi; Kasturi Datta
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

Review 6.  Hyphenated techniques for the analysis of heparin and heparan sulfate.

Authors:  Bo Yang; Kemal Solakyildirim; Yuqing Chang; Robert J Linhardt
Journal:  Anal Bioanal Chem       Date:  2010-09-19       Impact factor: 4.142

7.  3D Silk Fibroin-Gelatin/Hyaluronic Acid/Heparan Sulfate Scaffold Enhances Expression of Stemness and EMT Markers in Cholangiocarcinoma.

Authors:  Onanong Buhome; Molin Wongwattanakul; Jureerut Daduang; Temduang Limpaiboon
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

8.  Involvement of highly sulfated chondroitin sulfate in the metastasis of the Lewis lung carcinoma cells.

Authors:  Fuchuan Li; Gerdy B Ten Dam; Sengottuvelan Murugan; Shuhei Yamada; Taishi Hashiguchi; Shuji Mizumoto; Kayoko Oguri; Minoru Okayama; Toin H van Kuppevelt; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2008-10-16       Impact factor: 5.157

9.  Changes in composition and sulfation patterns of glycoaminoglycans in renal cell carcinoma.

Authors:  Ebru Ucakturk; Orkun Akman; Xiaojun Sun; Dilek Ertoy Baydar; Anil Dolgun; Fuming Zhang; Robert J Linhardt
Journal:  Glycoconj J       Date:  2015-12-14       Impact factor: 2.916

Review 10.  Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma.

Authors:  Francesco Dituri; Gianluigi Gigante; Rosanna Scialpi; Serena Mancarella; Isabel Fabregat; Gianluigi Giannelli
Journal:  Cancers (Basel)       Date:  2022-04-09       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.